GlassScriptPhysician profile
Dafna W Gordon
NPI 1679569388
$1,433.75
in general payments reported to CMS, 2019-2025
20 companies · $89.00 in 2025
The $89.00 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $655 · 2020: $47.52 · 2021: $62.39 · 2022: $132 · 2023: $311 · 2024: $136 · 2025: $89.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $398.59 | 2019-2025 | |
| Pfizer INC. | $219.46 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $179.22 | 2019-2023 | Entyvio |
| Celgene Corporation | $167.22 | 2023 | Zeposia |
| Janssen Biotech, INC. | $94.63 | 2019-2023 | Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.85 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $44.23 | 2021-2023 | Clenpiq |
| Ucb, INC. | $33.96 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $31.24 | 2022 | |
| Ironwood Pharmaceuticals, INC | $30.60 | 2019-2024 | |
| Allergan, INC. | $26.04 | 2019 | |
| Celltrion USA INC. | $24.47 | 2025 | Vegzelma |
| Romark Laboratories, Lc | $23.30 | 2019 | |
| Concordia Pharmaceuticals INC. | $21.10 | 2019 | |
| Dova Pharmaceuticals | $19.05 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $18.78 | 2019 | |
| Nestle Healthcare Nutrition INC. | $17.70 | 2021 | |
| Intercept Pharmaceuticals, INC. | $15.72 | 2019 | |
| Shionogi INC | $12.59 | 2020 | |
| Braintree Laboratories, INC. | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dafna Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.